Defective regulatory and effector T cell functions in patients with FOXP3 mutations
Open accessThe DOI matches its Crossref record; 52 of the 55 references it cites were found in a registry or an index.
Abstract
The autoimmune disease immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) is caused by mutations in the forkhead box protein P3 (FOXP3) gene. In the mouse model of FOXP3 deficiency, the lack of CD4+ CD25+ Tregs is responsible for lethal autoimmunity, indicating that FOXP3 is required for the differentiation of this Treg subset. We show that the number and phenotype of CD4+ CD25+ T cells from IPEX patients are comparable to those of normal donors. CD4+ CD25high T cells from IPEX patients who express FOXP3 protein suppressed the in vitro proliferation of effector T cells from normal donors, when activated by "weak" TCR stimuli. In contrast, the suppressive function of CD4+ CD25high T cells from IPEX patients who do not express FOXP3 protein was profoundly impaired. Importantly, CD4+ CD25high T cells from either FOXP3+ or FOXP3- IPEX patients showed altered suppression toward autologous effector T cells. Interestingly, IL-2 and IFN-gamma production by PBMCs from IPEX patients was significantly decreased. These findings indicate that FOXP3 mutations in IPEX patients result in heterogeneous biological abnormalities, leading not necessarily to a lack of differentiation of CD4+ CD25high Tregs but rather to a dysfunction in these cells and in effector T cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Loss of function mutations of Foxp3 lead to the manifestation of the scurfy phenotype in mice, corresponding to the IPEX-syndrome in humans [434].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [434]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells
R.Walker, M., Kasprowicz, D. J., Gersuk, V. H., Bènard, A., Van Landeghen, M., Buckner, J. H., & Ziegler, S. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19441 · Cited by 1,245
Setoguchi, R., Hori, S., Takahashi, T., & Sakaguchi, S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041982 · Cited by 1,235
Fantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R., & Neurath, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5149 · Cited by 1,135
Levings, M. K., Sangregorio, R., & Roncarolo, M.-G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1295 · Cited by 967
Ziegler, S. F. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090547 · Cited by 922
Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes
Lindley, S., Dayan, C. M., Bishop, A., Roep, B. O., Peakman, M., & Tree, T. I. M. (2005) · Diabetes · doi:10.2337/diabetes.54.1.92 · Cited by 861
Tolerance, not immunity, crucially depends on IL-2
Malek, T. R., & Bayer, A. L. (2004) · Nature Reviews Immunology · doi:10.1038/nri1435 · Cited by 820
CD4 Regulatory T Cells Prevent Lethal Autoimmunity in IL-2Rβ-Deficient Mice
Malek, T. R., Yu, A., Vincek, V., Scibelli, P., & Kong, L. (2002) · Immunity · doi:10.1016/s1074-7613(02)00367-9 · Cited by 779
Wildin, R. S., Smyk-Pearson, S., & Filipovich, A. H. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.8.537 · Cited by 711
Interleukin 2 Signaling Is Required for CD4+ Regulatory T Cell Function
Furtado, G. C., de Lafaille, M. A. C., Kutchukhidze, N., & Lafaille, J. J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020190 · Cited by 625
Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level
Roncador, G., Brown, P. J., Maestre, L., Hue, S., Martínez-Torrecuadrada, J. L., Ling, K.-L., Pratap, S., Toms, C., Fox, B. C., Cerundolo, V., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200526189 · Cited by 592
Gambineri, E., Torgerson, T. R., & Ochs, H. D. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200307000-00010 · Cited by 575
Thornton, A. M., Donovan, E. E., Piccirillo, C. A., & Shevach, E. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6519 · Cited by 560
IL-2, Regulatory T Cells, and Tolerance
Nelson, B. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.3983 · Cited by 556
Scurfin (FOXP3) Acts as a Repressor of Transcription and Regulates T Cell Activation
Schubert, L. A., Jeffery, E., Zhang, Y., Ramsdell, F., & Ziegler, S. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104521200 · Cited by 548
Bettelli, E., Dastrange, M., & Oukka, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501675102 · Cited by 545
Almeida, A. R. M., Legrand, N., Papiernik, M., & Freitas, A. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4850 · Cited by 468
The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs
Allan, S. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24685 · Cited by 444
Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans
Morgan, M. E., van Bilsen, J. H. M., Bakker, A. M., Heemskerk, B., Schilham, M. W., Hartgers, F. C., Elferink, B. G., van der Zanden, L., de Vries, R. R. P., Huizinga, T. W. J., et al. (2005) · Human Immunology · doi:10.1016/j.humimm.2004.05.016 · Cited by 418
Bacchetta, R., Bigler, M., Touraine, J. L., Parkman, R., Tovo, P. A., Abrams, J., de Waal Malefyt, R., de Vries, J. E., & Roncarolo, M. G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.493 · Cited by 416
Self-citationIn vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro
Klein, L., Khazaie, K., & von Boehmer, H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533365100 · Cited by 375
Kriegel, M. A., Lohmann, T., Gabler, C., Blank, N., Kalden, J. R., & Lorenz, H.-M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032158 · Cited by 351
Godfrey, W. R., Spoden, D. J., Ge, Y. G., Baker, S. R., Liu, B., Levine, B. L., June, C. H., Blazar, B. R., & Porter, S. B. (2005) · Blood · doi:10.1182/blood-2004-06-2467 · Cited by 297
Sawitzki, B., Kingsley, C. I., Oliveira, V., Karim, M., Herber, M., & Wood, K. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050419 · Cited by 297
Activation requirements for the induction of CD4+CD25+ T cell suppressor function
Thornton, A. M., Piccirillo, C. A., & Shevach, E. M. (2004) · European Journal of Immunology · doi:10.1002/eji.200324455 · Cited by 296
De novo generation of antigen-specific CD4+CD25+regulatory T cells from human CD4+CD25–cells
Walker, M. R., Carson, B. D., Nepom, G. T., Ziegler, S. F., & Buckner, J. H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407691102 · Cited by 285
Foxp3 and Natural Regulatory T Cells
Ramsdell, F. (2003) · Immunity · doi:10.1016/s1074-7613(03)00207-3 · Cited by 275
Inhibition of Human CD4+CD25+high Regulatory T Cell Function
Baecher-Allan, C., Viglietta, V., & Hafler, D. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6210 · Cited by 262
Antigen-Specific FoxP3-Transduced T-Cells Can Control Established Type 1 Diabetes
Jaeckel, E., von Boehmer, H., & Manns, M. P. (2005) · Diabetes · doi:10.2337/diabetes.54.2.306 · Cited by 232
Cellular and Molecular Characterization of the scurfy Mouse Mutant
Clark, L. B., Appleby, M. W., Brunkow, M. E., Wilkinson, J. E., Ziegler, S. F., & Ramsdell, F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.2546 · Cited by 211
FOXP3 acts as a rheostat of the immune response
Ochs, H. D., Ziegler, S. F., & Torgerson, T. R. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00231.x · Cited by 203
Godfrey, V. L., Wilkinson, J. E., Rinchik, E. M., & Russell, L. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5528 · Cited by 179
Differential expression of CTLA-4 among T cell subsets
JAGO, C. B., YATES, J., OLSEN SARAIVA CÂMARA, N., LECHLER, R. I., & LOMBARDI, G. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02478.x · Cited by 167
How defects in central tolerance impinge on a deficiency in regulatory T cells
Chen, Z., Benoist, C. O., & Mathis, D. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507014102 · Cited by 123
Owen, C. J., Jennings, C., Imrie, H., Lachaux, A., Bridges, N., Cheetham, T. D., & Pearce, S. H. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031080 · Cited by 107
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells
Walker, M., Kasprowicz, D. J., Gersuk, V. H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319441 · Cited by 99
The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis
Chang, X., Gao, J. X., Jiang, Q., Wen, J., Seifers, N., Su, L., Godfrey, V., Zuo, T., Zheng, P., & Liu, Y. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050157 · Cited by 95
Smyk‐Pearson, S., Bakke, A. C., Held, P. K., & Wildin, R. S. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02217.x · Cited by 59
Blazar, B. R., & Taylor, P. A. (2005) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2004.11.005 · Cited by 32
Marquis, E., Robert, J., Bouvattier, C. M., Bellanné‐Chantelot, C., Junien, C., & Diatloff-Zito, C. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.5.370 · Cited by 24
Godfrey, W. R., Spoden, D. J., Ge, Y. G., Baker, S. R., Liu, B., Levine, B. L., June, C. H., Blazar, B. R., & Porter, S. B. (2004) · Blood · doi:10.1182/blood.v104.11.2124.2124 · Cited by 8
The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis
Wen, J., Su, L., Chang, X., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/htw1-hq60 · Cited by 7
Cited by
Genetics, pathogenesis and clinical interventions in type 1 diabetes
Bluestone, J. A., Herold, K., & Eisenbarth, G. (2010) · Nature · doi:10.1038/nature08933 · Cited by 1,265
Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans
Grazia Roncarolo, M., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K., & Levings, M. K. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00420.x · Cited by 1,173
Self-citationType 1 diabetes immunotherapy using polyclonal regulatory T cells
Bluestone, J. A., Buckner, J. H., Fitch, M., Gitelman, S. E., Gupta, S., Hellerstein, M. K., Herold, K. C., Lares, A., Lee, M. R., Li, K., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad4134 · Cited by 1,033
“Mutations or deficiency in the FOXP3 gene in scurfy mice or immunodysregulation polyendocrinopathy enteropathy X-linked syndrome (IPEX) patients results in a reduced and/or nonfunctional Treg compartment, leading to a fatal multiorgan autoimmune disease (12).”
BackgroundType 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022
“One such example is found in the IPEX syndrome (immune dysregulation, polyendocrinopathy, enteropathy, X-linked), in which mutations in the Foxp3 transcription factor lead to the dysfunction of regulatory T cells (Tregs) and wasting multiorgan autoimmunity (26, 77, 474).”
BackgroundGuidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Metadata
- Authors
- Bacchetta, R.
- Affiliations
- The San Raffaele Telethon Institute for Gene Therapy (IT)
- Corresponding author
- Bacchetta, R.
- ORCID
- Bacchetta, R.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-06-01
- Volume
- 116
- Issue
- 6
- Pages
- 1713-1722
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1472239
- OpenAlex
- W2095671247
- Cited by
- 511
- References
- 55
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 14 · 2023: 12 · 2022: 18 · 2021: 26 · 2020: 19 · 2019: 17 · 2018: 25 · 2017: 31 · 2016: 21 · 2015: 20 · 2014: 29 · 2013: 33 · 2012: 36
- FWCI
- 16.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Florence Research (University of Florence) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- Università degli Studi di Firenze
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (AI48779, R01AI048779)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- FOXP3 mutations, IPEX syndrome, regulatory T cells, CD4+CD25high T cells, Treg suppressive function, effector T cells, T cell proliferation inhibition, interleukin-2, interferon-gamma, autoimmunity
- MeSH terms
- Animals, Child, Preschool, Disease Models, Animal, Female, Humans, Infant, Interleukin-2, Leukocytes, Mononuclear, Male, Phenotype, Promoter Regions, Genetic, Protein-Losing Enteropathies, Biomarkers, CD4-Positive T-Lymphocytes, T-Lymphocyte Subsets, Cytokines, Polyendocrinopathies, Autoimmune, Jurkat Cells, Mutation, Missense, Genetic Diseases, X-Linked, T-Lymphocytes, Regulatory, Mice, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.